Abstract

Genome-wide association studies have identified numerous variants associated with human complex traits, most of which reside in the non-coding regions, but biological mechanisms remain unclear. However, assigning function to the non-coding elements is still challenging. Here we apply Activity-by-Contact (ABC) model to evaluate enhancer-gene regulation effect by integrating multi-omics data and identified 544,849 connections across 20 cancer types. ABC model outperforms previous approaches in linking regulatory variants to target genes. Furthermore, we identify over 30,000 enhancer-gene connections in colorectal cancer (CRC) tissues. By integrating large-scale population cohorts (23,813 cases and 29,973 controls) and multipronged functional assays, we demonstrate an ABC regulatory variant rs4810856 associated with CRC risk (Odds Ratio = 1.11, 95%CI = 1.05–1.16, P = 4.02 × 10−5) by acting as an allele-specific enhancer to distally facilitate PREX1, CSE1L and STAU1 expression, which synergistically activate p-AKT signaling. Our study provides comprehensive regulation maps and illuminates a single variant regulating multiple genes, providing insights into cancer etiology.

Here, the authors apply the Activity-by-Contact (ABC) model to infer enhancer-gene regulation and the effect of associated variants across multiple cancer types, integrating genetic and multi-omics data. Then, they explore the mechanisms associated with ABC regulatory variants in colorectal cancer.

Details

Title
Genome-wide enhancer-gene regulatory maps link causal variants to target genes underlying human cancer risk
Author
Ying, Pingting 1 ; Chen, Can 1 ; Lu, Zequn 1 ; Chen, Shuoni 2 ; Zhang, Ming 2 ; Cai, Yimin 2   VIAFID ORCID Logo  ; Zhang, Fuwei 2 ; Huang, Jinyu 2 ; Fan, Linyun 2 ; Ning, Caibo 2 ; Li, Yanmin 2 ; Wang, Wenzhuo 2 ; Geng, Hui 2 ; Liu, Yizhuo 2 ; Tian, Wen 2 ; Yang, Zhiyong 3 ; Liu, Jiuyang 4 ; Huang, Chaoqun 4 ; Yang, Xiaojun 4 ; Xu, Bin 5 ; Li, Heng 6 ; Zhu, Xu 7 ; Li, Ni 8   VIAFID ORCID Logo  ; Li, Bin 2 ; Wei, Yongchang 9 ; Zhu, Ying 2 ; Tian, Jianbo 1   VIAFID ORCID Logo  ; Miao, Xiaoping 10   VIAFID ORCID Logo 

 Wuhan University, Department of Epidemiology and Biostatistics, School of Public Health, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153); Zhongnan Hospital of Wuhan University, Department of Gastrointestinal Oncology, Wuhan, China (GRID:grid.413247.7) (ISNI:0000 0004 1808 0969); Renmin Hospital of Wuhan University, Department of Radiation Oncology, Wuhan, China (GRID:grid.412632.0) (ISNI:0000 0004 1758 2270) 
 Wuhan University, Department of Epidemiology and Biostatistics, School of Public Health, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153) 
 Zhongnan Hospital of Wuhan University, Department of Hepatobiliary and Pancreatic Surgery, Wuhan, China (GRID:grid.413247.7) (ISNI:0000 0004 1808 0969) 
 Wuhan University, Department of Gastrointestinal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153) 
 Wuhan University, Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153) 
 Huazhong University of Science and Technology, Department of Urology, Tongji Hospital of Tongji Medical College, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223) 
 Renmin Hospital of Wuhan University, Department of Gastrointestinal Surgery, Wuhan, China (GRID:grid.412632.0) (ISNI:0000 0004 1758 2270) 
 Chinese Academy of Medical Sciences and Peking Union Medical College, Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Beijing, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839) 
 Zhongnan Hospital of Wuhan University, Department of Gastrointestinal Oncology, Hubei Cancer Clinical Study Center, Wuhan, China (GRID:grid.413247.7) (ISNI:0000 0004 1808 0969) 
10  Wuhan University, Department of Epidemiology and Biostatistics, School of Public Health, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153); Zhongnan Hospital of Wuhan University, Department of Gastrointestinal Oncology, Wuhan, China (GRID:grid.413247.7) (ISNI:0000 0004 1808 0969); Renmin Hospital of Wuhan University, Department of Radiation Oncology, Wuhan, China (GRID:grid.412632.0) (ISNI:0000 0004 1758 2270); Huazhong University of Sciences and Technology, Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223) 
Pages
5958
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2868491139
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.